DrucySaretteBorowitzMD
Pediatric Pulmonology • Buffalo, NYClinical Professor of Pediatrics, SUNY Buffalo
Are you Dr. Borowitz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
219 Bryant St
Buffalo, NY 14222Phone+1 716-878-7524Fax+1 716-839-6740
Summary
- Dr. Drucy Borowitz, MD is a pediatric pulmonologist in Buffalo, New York. She is currently licensed to practice medicine in New York. She is affiliated with KALEIDA Health and is a Clinical Professor of Pediatrics at SUNY Buffalo.
Education & Training
University of California (San Francisco) School of MedicineFellowship, Clinical Nutrition, 1982 - 1985
Childrens Hospital of PhiladelphiaInternship, Transitional Year, 1979 - 1980
Weill Cornell MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1988 - 2024- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Buffalo Spree Magazine Castle Connolly, 2008, 2010-2014
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Baby Observational and Nutritional Study Start of enrollment: 2011 Dec 01
- Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 381 citationsConsensus report on nutrition for pediatric patients with cystic fibrosis.Drucy Borowitz, Robert D. Baker, Virginia A. Stallings
Journal of Pediatric Gastroenterology and Nutrition. 2002-09-01 - 377 citationsClinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic FibrosisSteven M. Rowe, Sonya L. Heltshe, Tanja Gonska, Scott H. Donaldson, Drucy Borowitz
American Journal of Respiratory and Critical Care Medicine. 2014-07-15 - 165 citationsLong-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)Edward F. McKone, Drucy Borowitz, Pavel Drevinek, Matthias Griese, Michael W. Konstan
The Lancet. Respiratory Medicine. 2014-11-01
Press Mentions
- Cystic Fibrosis Center Prioritizes Screening for Depression, Anxiety in Patients, CaregiversJune 8th, 2021
CFF Programs Strive to Reduce Patients’ IsolationDecember 27th, 2019- CFF Offers Emotional Send-off to Retiring CEO Preston CampbellDecember 12th, 2019
- Join now to see all
Professional Memberships
- Fellow
